GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pixium Vision SA (XPAR:ALPIX) » Definitions » ROE % Adjusted to Book Value

Pixium Vision (XPAR:ALPIX) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Pixium Vision ROE % Adjusted to Book Value?

Pixium Vision's ROE % for the quarter that ended in Jun. 2023 was 0.00%. Pixium Vision's PB Ratio for the quarter that ended in Jun. 2023 was N/A. Pixium Vision's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was N/A.


Pixium Vision ROE % Adjusted to Book Value Historical Data

The historical data trend for Pixium Vision's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pixium Vision ROE % Adjusted to Book Value Chart

Pixium Vision Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.89 -25.73 -28.16 -25.17 -

Pixium Vision Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.74 -27.98 -5.36 - -

Competitive Comparison of Pixium Vision's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Pixium Vision's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pixium Vision's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pixium Vision's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Pixium Vision's ROE % Adjusted to Book Value falls into.



Pixium Vision ROE % Adjusted to Book Value Calculation

Pixium Vision's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-695.82% / N/A
=N/A

Pixium Vision's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pixium Vision ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Pixium Vision's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Pixium Vision (XPAR:ALPIX) Business Description

Traded in Other Exchanges
N/A
Address
74 rue du Faubourg Saint Antoine, Paris, FRA, 75012
Pixium Vision SA is engaged in the business of developing implantable medical devices to treat blindness resulting from the degeneration of retinal photoreceptor cells.

Pixium Vision (XPAR:ALPIX) Headlines

No Headlines